J. Michael Pearson
CEO of Valeant Pharmaceuticals; oversaw rapid roll-up growth and deceptive specialty pharmacy distribution channel, penalised by SEC.
- Name: J. Michael Pearson
- Jurisdiction: US
- Criminal Sentence: No prison sentence.
- Officer & Director Bar: No statutory bar recorded.
- Monetary Sanctions: Disclosed in docket narrative.
- Case Records: Named in 1 primary fraud dossier(s).
PRIMARY ENFORCEMENT CASES INVOLVING J. MICHAEL PEARSON
PRIMARY SOURCE DOSSIERS| Case Title | Jurisdiction | Status | Primary Scheme | Role | Outcome / Sanction |
|---|---|---|---|---|---|
| Valeant Pharmaceuticals: Undisclosed Captive Pharmacy Philidor and Channel Stuffing | CA | SETTLED | channel stuffing | OFFICER | Used secret captive specialty pharmacy Philidor to prematurely recognize revenue and stuff distribution channels. |
ROLE & CASE RECORD: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
FULL CASE DOSSIER →Used secret captive specialty pharmacy Philidor to prematurely recognize revenue and stuff distribution channels.
The company manipulated its accounting records by executing schemes under channel-stuffing. Financial reports filed with market regulators contained material misstatements that distorted true financial condition.
Issuer: Valeant Pharmaceuticals International, Inc. • Primary Regulator: U.S. Securities and Exchange Commission • Action Date: September 20, 2017
Official Regulatory & Court Citations
- [ENF-2015-valeant] Enforcement Action: Valeant Pharmaceuticals: Undisclosed Captive Pharmacy Philidor and Channel Stuffing (September 20, 2017): Used secret captive specialty pharmacy Philidor to prematurely recognize revenue and stuff distribution channels. Official Record ↗